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The Proper Conduct of Valsalva Maneuver
in the Detection of Patent Foramen Ovale
The role of patent foramen ovale (PFO) in cryptogenic stroke has
received increasing attention in recent times (1). Cryptogenic
stroke via PFO is a form of paradoxical embolism. Formerly
diagnosable during life only by cardiac catheterization (2), PFO-
associated paradoxical embolism can nowadays be diagnosed non-
invasively by echocardiography. Performance of a Valsalva maneu-
ver is an integral part of the echocardiographic examination.
Unfortunately, in most of the textbooks on echocardiography and
published literature on the detection of PFO by echocardiography,
the use of the Valsalva maneuver was either not mentioned or not
specified as to which phase should be imaged.
Under normal conditions, a PFO does not allow an interatrial
shunt to occur from either left to right or from right to left.
However, in cases of increased right atrial pressure, as in pulmo-
nary embolism or during a Valsalva maneuver such as when
straining during defecation or childbirth, a right-to-left interatrial
shunt will occur through a PFO. It should be noted that it is not
during the strain phase but during the release phase of the Valsalva
maneuver that imaging of the interatrial septum should be per-
formed.
To illustrate this point, there is the case of a 50-year-old woman
with cerebral embolism accompanying pulmonary embolism, in
whom indicator dilution curves using ascorbate as an indicator and
polarographic technique for detection (Fig. 1) (3) were performed.
In each panel, the platinum electrode placed percutaneously in the
femoral artery (FA) was the sensing side following right atrial
(RA) injection of 300 mg ascorbate; recordings at a slow paper
speed were made simultaneously with electrocardiographic lead II
(L2) and right atrial pressure (RAp), except in the 2nd and 4th
panels (Fig. 1) where connection with the strain gauge was turned
off. There was apparently no evidence of a right-to-left interatrial
shunt both before and during the strain phase of the Valsalva
maneuver. However, following release of the Valsalva maneuver, as
shown in panel 3, of Figure 1, there was a small right-to-left (R3L)
interatrial shunt, which became larger, as depicted in the 4th panel,
following release of a more strenuous Valsalva maneuver.
Therefore, it is extremely important to continue echocardio-
graphic imaging not only during the strain phase but also the
release phase of the Valsalva maneuver so as not to miss the
diagnosis of paradoxical embolism (2). Furthermore, clinicians
should not just write on the request form “to rule out cardiogenic
emboli” when sending a patient with cryptogenic stroke to the
echocardiographic laboratory. What the echocardiographic tech-
nician or even the echocardiographer usually does is concentrate on
ruling out a left atrial thrombus, a left atrial myxoma, mitral valve
prolapse, vegetations on the mitral or aortic valve, a left ventricular
thrombus or ventricular aneurysm, dilated cardiomyopathy, or
atherosclerotic plaques in the ascending aorta. Of couse, it is also
possible to detect an interatrial septal defect or an atrial septal
aneurysm or a PFO, the last usually only on transesophageal
echocardiography. To rule out paradoxical embolism, one needs to
reverse the interatrial pressure gradient, because normally left atrial
pressure is higher than right atrial and therefore no right-to-left
shunt will occur, unless we artificially reverse this gradient by
raising the right atrial pressure above the left atrial, such as by
performance of a Valsalva maneuver. Therefore, it is very impor-
tant to put on the requisition form to the echocardiographic
laboratory not just “to rule out cardiogenic emboli” but also to “rule
out paradoxical embolism.” For the latter it is not only necessary
during echocardiography to perform a Valsalva maneuver follow-
ing the intravenous injection of agitated saline or contrast medium
but also to obtain images during both the strain phase and the
release phase of the Valsalva maneuver (2–14).
That underdiagnosis of PFO by echocardiography in patients
with paradoxical embolism can result when appropriate technique
is not used has been demonstrated in the past (15, 16). But it is not
so much of a question of transesophageal versus transthoracic
approach that is important in the echocardiographic diagnosis of
paradoxical embolim as is the proper conduct of the Valsalva
maneuver during the echocardiographic examination. As a matter
of fact, the sedated state of the patient necessary for the trans-
Figure 1. Indicator dilution curves using ascorbate as an indicator and polarographic technique for detection of paradoxical embolism were performed
before, during, and after the Valsalva maneuver in a 50-year-old female patient with cerebral embolism accompanying pulmonary embolism. A platinum
electrode placed in the femoral artery (FA) was the sensing side after right atrial (RA) injection (Inj) of 300 mg ascorbate. L2  ECG lead II; RAp  right
atrial pressure. See text for details.
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esophageal examination often prevents the patient from perform-
ing an effective or adequate Valsalva maneuver, which is the
essential part of the examination.
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